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To improve the test-retest reproducibility of coronary plaque 18F-sodium fluoride (18F-NaF) 
positron emission tomography (PET) uptake measurements.  
Methods 
We recruited 20 patients with coronary artery disease who underwent repeated hybrid 
PET/CT angiography (CTA) imaging within 3 weeks. All patients had 30-min PET 
acquisition and CTA during a single imaging session. Five PET image-sets with 
progressive motion correction were reconstructed, (i) a static dataset using all the data 
(no-MC), (ii) end-diastolic PET (Standard), (iii) cardiac motion corrected (MC), (iv) 
combined cardiac and gross patient motion corrected (2xMC) and, (v) cardiorespiratory 
and gross patient motion corrected (3xMC). In addition to motion correction, all datasets 
were corrected for variations in the background activities which are introduced by 
variations in the injection-to-scan delays (background blood pool clearance correction, 
BC). Test-retest reproducibility of PET target-to-background ratio (TBR) was assessed by 
Bland-Altman analysis and coefficient of reproducibility.  
Results 
A total of 47 unique coronary lesions were identified on CTA. Motion correction in 
combination with BC improved the PET TBR test-retest reproducibility for all lesions 
(coefficient of reproducibility: Standard = 0.437, No-MC = 0.345 (27% improvement), 
Standard+BC = 0.365 (20% improvement), no-MC+BC = 0.341 (27% improvement), 
MC+BC = 0.288 (52% improvement), 2xMC+BC = 0.278 (57% improvement) and 
3 
 
3xMC+BC = 0.254 (72% improvement), all p<0.001). Importantly in a sub analysis of 18F-
NaF-avid lesions with gross patient motion >10mm following corrections reproducibility 
was improved by 133% (coefficient of reproducibility: standard= 0.745, 3xMC= 0.320). 
Conclusion  
Joint corrections for cardiac, respiratory and gross patient motion in combination with 
background blood pool corrections markedly improve test-retest reproducibility of 
coronary 18F-NaF PET.  
Keywords: Data-driven motion detection, Motion correction, PET/CT, Cardiac PET, 





18F-NaF -  18F-sodium fluoride 
PET  - Positron Emission Tomography 
CTA -  coronary Computed Tomography Angiography 
MC - cardiac motion corrected 
2xMC - cardiac and gross patient motion corrected 
3xMC - cardiac, respiratory and gross patient motion corrected 
BC -  Background blood pool clearance correction 
TBR  - Target to Background ratio 
SUV - Standardized uptake value 





Positron Emission Tomography (PET) in combination with Computed Tomography 
(CT) angiography (CTA) holds promise as a non-invasive technology for identification of 
high-risk plaques in patients with coronary artery disease [1–4].  
Clinical implementation of coronary PET imaging is, however, challenging, as 
coronary lesions are small and continuously move during the acquisition. Further, only 
modest target to background ratio (TBR) differences between culprit and non-culprit 
plaques (~34%) have been reported for 18F-sodium fluoride PET (18F-NaF) [1]. 
Importantly, the TBR measurements are significantly degraded by cardiorespiratory and 
patient motion during the 30-min scans. It has been shown that physiological tidal 
breathing can cause the heart to move >1 cm [5]. The amplitude of coronary artery motion 
during the cardiac cycle is about 8-26 mm, depending on the artery and location, with the 
highest motion in the right coronary artery [6]. Further, typical gross patient motion (other 
than cardiorespiratory motion) results in repositioning of the heart, typically by 5-15mm, 
during a 30-min scan [7]. These observations are of key significance for coronary lesions 
with dimensions measured in single millimeters. 
To reduce the effect of motion of the coronary arteries, end-diastolic phase images have 
been selected in studies to date [1,6,8] but this strategy uses only 25% of PET counts, 
consequently increasing image noise [9]. Recent studies proposed improvements by 
correcting for cardiac motion [6,9], or by combining end-diastolic imaging with corrections 
for gross patient motion [7], but did not include corrections for respiratory motion, nor test 
how these corrections affect the scan-rescan reproducibility. Additionally, TBR values are 
affected by variations in the tracer uptake time (injection to scan delay) [10,11]. 
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Consequently, the reproducibility of this promising PET technique remains suboptimal, 
which hampers its translation into clinical routine.  
In this study, we demonstrate that a novel technique for coronary PET processing which 
combines triple motion correction (3xMC) (cardiorespiratory and gross patient motion) 
with adjustments for injection-to-scan delays significantly improves the scan-rescan 
reproducibility.   






MATERIALS AND METHODS 
Study Population 
The study population comprised of twenty patients who underwent repeated hybrid 
18F-NaF PET/CT examinations of the coronary arteries. Scans were repeated within 3 
weeks as a part of the ongoing DIAMOND (Dual Antiplatelet Therapy to Reduce 
Myocardial Injury, NCT02110303) study. One patient was excluded from the study due to 
an incomplete saving of the list mode PET file (PET raw data). Patient characteristics are 
described in Table 1.  
Inclusion criteria for the study included angiographically confirmed multivessel 
coronary artery disease defined as either previous revascularization or stenosis > 50%. 
Exclusion criteria included: an acute coronary syndrome within 12 months prior to the 
examination, renal dysfunction (estimated glomerular filtration rate ≤30 mL/min/1.73 m2) 
and contraindication to CT-contrast media. This study was approved by the local 
investigational review board (Edinburgh, UK) and written informed consent was obtained 
from all subjects. 
Imaging Protocol  
PET/CT. Patients underwent 30-min list-mode PET-emission acquisitions 
approximately one hour after (66±9 min, range: 59-101 min) injection of 18F-NaF (248±9 
MBq). All patients were scanned in supine position with arms positioned above the head 
in a 128-slice Biograph mCT system (Siemens Healthineers, Knoxville, USA). A low-dose 
CT for attenuation correction was acquired immediately before the PET acquisition (120 
kV, 50 mAs, 3-mm slice thickness). All patients were imaged with 3-lead 
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electrocardiogram (cardiac gating), without the use of additional external markers for 
tracking of patient or respiratory motion.   
CT angiography. For anatomical localization of PET uptake, coronary CTA was 
performed immediately after the PET acquisition. The CTA imaging parameters including 
prospective gating, 330 milliseconds rotation time, body-mass index (BMI) dependent 
voltage (BMI <25, 100 kV; BMI ≥25, 120 kV), and tube-current time product of 160-245 
mAs. Patients were administered beta-blockers (orally or intravenously) to achieve a 
target heart-rate of <60 beats/min. A BMI-dependent bolus-injection of contrast media 
(400 mg/mL) was administered to the patients with a flow of 5-6 mL/s after determining 
the appropriate trigger delay defined by a test bolus of 20 mL of contrast material. CTA 
studies were assessed visually for percent stenosis according to SCCT guidelines [12]. 
Image reconstruction  
Five different PET image reconstructions were evaluated in this study: (i) a static 
reconstruction using all the acquired data (no-MC), (ii) end-diastolic reconstruction using 
25% of the acquired data (standard) [1], (iii) cardiac motion corrected reconstruction  
(MC), (iv) combined cardiac and gross patient motion corrected reconstruction (2xMC), 
and (v) combined cardiac, respiratory and gross patient motion corrected reconstruction 
(3xMC). All reconstructions except the end-diastolic reconstruction were using 100% of 
the acquired data.  
The five datasets were reconstructed with vendor provided software (JS-Recon12, 
Siemens, Knoxville, USA) from the PET list mode data (raw PET data). All PET image 
reconstructions were performed with corrections for time-of-flight and point-spread 
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function, using 2 iterations, 21 subsets. The no-MC reconstruction was performed without 
any gating, whereas all other reconstructions were performed with 4 cardiac gates 
(time/phase based) (all datasets); the number of gross patient motion frames depended 
on the motion of the individual patients and scans (range 2-10 frames [7]) (2xMC, 3xMC), 
while the number of respiratory gates was fixed to 4 (amplitude-based gating [13]) 
(3xMC). Because the gross patient and respiratory motion was detected directly in 
sinogram space, it was not possible to apply any direct motion correction of the 
corresponding AC maps owing to the complex translations from the motion vectors 
obtained in projection space to image-space [7].  
Motion detection 
The overall scheme for motion detection is shown in Figure 1.  
Cardiac gating information was obtained from a 3-lead electrocardiogram. Respiratory 
and gross patient motion detection was achieved using only the acquired PET list data 
without the use of any external markers. The data-driven motion detection techniques 
were based on center-of-mass analyses of single-slice rebinned sinograms [14] created 
for every 200 ms of the acquisition, as described in our previous study [7]. In brief, the 
detection of the gross patient motion was obtained for the entire field-of-view [7], while 
the respiratory motion was detected only for the diaphragm using a 2cm (radius) 
boundary.  
Motion correction 
The PET motion correction was obtained through co-registration of gated  PET-images 
(PET-PET image co-registration), using a dedicated coronary PET/CT software 
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(FusionQuant, Cedars-Sinai Medical center) which employs a non-linear co-registration 
of the images [8] (Figure 1). The resulting motion corrected datasets (MC, 2xMC, and 
3xMC) were obtained through averaging of the co-registered images. To ensure accurate 
co-registration of the coronary plaques, the motion compensation was focused on the 
coronary tree utilizing segmentations of the coronary arteries (including a radius of 1cm 
surrounding the center of the coronary arteries) obtained from the CTA images using a 




PET Quantification. Prior to image analysis, PET and CTA reconstructions were 
reoriented, fused and co-registered in all 3 planes (a rigid X-Y-Z translation was 
performed). Key points of reference were the sternum, vertebrae, blood pool in the left 
and right ventricle (based upon high 18F-fluoride activity in the blood pool in comparison 
to the surrounding myocardium) and the great vessels [15]. 18F-NaF PET uptake was 
measured in all coronary segments with a CTA >25% stenosis, a vessel diameter ≥2 mm, 
which have not been stented and presented with image quality suitable for visual stenosis 
assessment. The 18F-NaF uptake in the lesions was evaluated in the 3D spherical volume 
of interest (VOI) (radius 5 mm), and the background blood pool activity was determined 
by a cylindrical VOI (radius=10 mm, length=15 mm), placed in the right atrium at the level 
of the takeoff of the right coronary artery. We used the same VOIs for all 5 reconstructions 
evaluated in this study. TBR values for all 5 reconstructions were calculated by dividing 
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the maximal standard uptake value (SUVmax) of the lesions by the mean SUV obtained 
from the blood pool (SUVBackground)[16].   
The impact of the motion (cardiorespiratory and gross patient motion) was 
evaluated in three subsets of lesions, (a) in all CTA-defined lesion locations (b) in all 
lesions with 18F-NaF-avid uptake and (c) in 18F-NaF-avid lesions with gross patient motion 
>10 mm. The magnitude of the gross patient motion repositioning events was calculated 
in 3D from motion vectors obtained during the PET-PET co-registrations.   
 Blood pool correction.  It has been recently reported that TBRs for 18F-NaF varies with 
injection-to-scan time [10]. Based on the data reported in [10], the decay-corrected tracer 
activity in the lesions does not change during a 2-hour period, while the blood pool activity 
is cleared at a rate of 1.5092*e-0.004*t (R2=0.81). From these findings, we propose to 
introduce a correction factor which harmonizes the SUVBackground activities to a reference 
time (60 minutes post-injection) (Equation 1).  
𝑆𝑆𝑆𝑆𝑆𝑆𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵  𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝑐𝑐𝐵𝐵𝑐𝑐𝑐𝑐𝐵𝐵 = 𝑆𝑆𝑆𝑆𝑆𝑆𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 ∗ 𝑒𝑒−0.004∗(60−𝑐𝑐)   (1) 
where t represents the injection-to-scan delay in minutes.  
Diagnostic evaluation of 18F-NaF PET 
All lesions were quantified based on the CTA based lesion position, categorized as 18F-
NaF-avid and 18F-NaF-negative on standard PET using a previously validated 
methodology [1,17]. In brief, lesions with TBR ≥1.25 and focal uptake on the site of the 
CTA-assessed lesion were considered 18F-NaF-avid, while lesions without focal uptake 




The data were tested for normality using the Shapiro-Wilk test. Statistical analysis 
was performed in MatLab (Mathworks). Continuous variables were presented as 
mean±SD (standard deviation). Assessment of the test-retest reproducibility before and 
after corrections for motion and blood-pool effects were obtained using descriptive 
statistics with Bland-Altman plots as well as the coefficient of reproducibility. 
Improvements in the test-retest reproducibility were evaluated by Pitman-Morgan test. A 






 The patients underwent repeated 18F-NaF PET / CTA hybrid imaging studies within 
a maximum of 21 days (mean 12±5 days). 47 unique lesions were identified on the CTA-
images with 15 18F-NaF-avid, 30 18F-NaF-negative and 2 lesions with discordant 
evaluations (TBR>1.25 in one scan, while TBR <1.25 in the other scan) on standard PET 
images.  
Standard analyses  
On standard PET images, TBR across all lesions were 1.18±0.48, with 18F-NaF-avid 
lesions having TBR values of 1.65±0.38 (Table 2). Test-retest coefficients of 
reproducibility for TBR were 0.437 for all lesions and 0.628 for18F-NaF-avid lesions. In 
comparison, evaluations of no-MC data, the TBR values were significantly lower 
1.06±0.32 (All lesions) and 1.37±0.23 (18F-NaF-avid) (p<0.001 and p<0.004, respectively) 
with test-retest reproducibility coefficients of 0.345 and 0.490, respectively (Table 2).  
Reproducibility with Motion Correction  
The motion corrected datasets had significantly improved test-retest reproducibility of the 
lesion assessments in comparison to the standard datasets, all p<0.05 (Pitman-Morgan 
test) (Table 2). Figure 2 shows that the progressive motion compensation techniques 
steadily improved the test-retest reproducibility for all delineated lesions.  
Background blood pool clearance correction 
All datasets were corrected for the variances in the injection to scan delay by 
standardizing the tracer SUV measurements in the background region to 60-min after 18F-
14 
 
NaF administration (Table 3). Due to the mean delay time (66±9 min, range 59-101 min) 
being longer than 60 minutes, our blood pool correction resulted in a slight reduction of 
TBR values by 2.5±3.8% (range: -0.4% to 17.8%), p=0.98 (Table 4).  
Reproducibility with motion correction and BC 
Blood pool correction further improved the test-retest reproducibility of TBR for all 
datasets. For all lesions as a stand-alone correction (Standard vs. Standard+BC), the 
coefficient of reproducibility was improved by 20%, in combination with 3xMC, the 
reproducibility was improved by 72% (Table 4, Figure 3).  In the sub-analysis of 18F-NaF-
avid lesions, 3xMC +BC correction improved the reproducibility by 78% (Table 4, Figure 
S1). Importantly in a subset of lesions with larger patient motion during one of the scans 
(>10 mm), 3xMC+BC correction lead to a 133% improvement in reproducibility (Table 5, 
Figure 4).  
Two lesions with discordant assessment and two lesions considered 18F-NaF-negative 
on the standard assessment were reclassified as being 18F-NaF-avid on 2 scans following 
corrections for both cardiorespiratory and gross patient motion (3xMC). For the lesions 
with discordant analyses on test and retest scans (2 lesions), following 3xMC+BC 
corrections the TBR values increased from (TBR: standard = 1.24 and 1.22, on scan 1 
and scan 2 respectively), to (TBR = 1.44 and 1.42, on scan 1 and scan 2 respectively). 
The two lesions perceived 18F-NaF-negative had an average increment of 16±1% in the 
TBR assessment following 3xMC+BC (TBR: standard =1.16±0.1, 3xMC+BC = 1.34±0.1). 
Figure 5 displays two case-examples on the effect of the described motion correction 
techniques. In both cases, the detrimental motion caused discordant evaluations of the 
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lesions in the test-retest evaluation. Following 3xMC and BC corrections, both lesions 





 In this study, we evaluated the reproducibility of TBR measurements of coronary 
plaque activity before and after corrections for cardiorespiratory and gross patient motion 
as well as quantitative correction of the background activity according to the variations in 
the injection-to-scan delay. To our knowledge, this is the first time such comprehensive 
triple gating motion correction is reported for any PET imaging. We demonstrate that the 
reproducibility using the standard assessment (end-diastolic imaging) is impaired by 
motion during the acquisition, reduced count rate, and injection time variability. Motion 
corrected reconstructions utilizing all image data and adjustment for injection-to-scan 
delay markedly improved test-retest reproducibility.   
High reproducibility of coronary PET lesion uptake is a critical prerequisite for the 
translation of coronary plaque imaging into clinical practice. The standard approach used 
to date is based on end-diastolic imaging [1,17]. The rationale behind using end-diastolic 
images for the assessment of coronary plaque activity was to improve TBR  and mitigate 
the detrimental effects of cardiac motion, as demonstrated in this study (Table 2) [1,18]. 
Unfortunately, this approach has several implications on TBR values, with two substantial 
problems pertaining to the increased noise in the images introduced by capturing counts 
from only one-fourth of the cardiac cycle and the remaining embedded motion-blur 
introduced by both respiratory and gross patient motion [7]. These limitations result in 
compromised test-retest reproducibility, which consequently makes it difficult to set 
accurate TBR thresholds for positive or negative findings. In addition, the use of TBR as 
a clinical measure for the lesion uptake might not be ideal because of the varying uptake 
in the background  introduced by variations in the injection-to-scan delays [10,11,19]. In 
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this study, the variations in the injection-to-scan delays were found to reduce the 
repeatability by 19% for all lesions (Table 3), which were corrected using a simple 
correction for blood clearance (BC). 
To ameliorate the shortcomings of the noise and patient motion, motion correction of 
cardiac contraction has been employed [6,9,10]. Additionally, in a recent study, it was 
found that the long acquisition duration (30 minutes) lead to multiple events of patient 
repositioning during emission scanning [7], a pattern that was also found in the current 
study. In this study, we combined corrections for gross patient motion with additional 
novel corrections for respiratory motion detected PET from list mode data to achieve total 
triple gated motion corrected reconstructions. These additional corrections improved 
test/retest reproducibility by an additional 12% to 42% in comparison to cardiac 
contraction correction (MC) as a standalone technique (Table 2). Overall, when BC and 
3xMC were combined, the reproducibility was improved by 77% for 18F-NaF-avid lesions 
(Table 4, Figures 3-4).  
Despite significant improvement, the reproducibility remains modest (Coefficient of 
reproducibility of 25%) after applying the triple corrections proposed in this study. 
Therefore, further reductions in the inter-scan variation is still warranted. The 
reproducibility coefficients were lower for the 18F-NaF-avid lesions in the current study. 
This is expected to partly be caused by the background activities and partly by the 
increased noise in the SUVmax uptake for the 18F-NaF avid lesions, a consequence of  the 
quasi-Poisson nature of the PET-detections and single voxel of activity sampled [20]. 
While the use of SUVmean could reduce the noise, and thereby some of the variation in 
the measurements, it is not feasible as accurate delineation of small coronary plaques is 
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impossible [19]. An alternative method to reduce the noise in the TBR assessment could 
be the use of an average of the N hottest voxels within the lesion (SUVmax-N , with N>1), 
a method that has proven to be stable for oncological PET scans [21] in combination with 
more advanced motion correction techniques. However, the use of SUVmax-N mandates 
finding an optimum number of voxels and, thus, a new TBR cut-off value to determine the 
18F-NaF-avid lesions. This was outside of the scope of this study but should be considered 
for upcoming studies.  
  
The combination of 3xMC and BC not only improved the reproducibility but also led to 
reclassification of 4 lesions, of which 2 were perceived negative on both scans and 2 had 
discordant evaluations on the standard end-diastolic image sets. The 3xMC+BC led to 
concordant test-retest findings in cases with originally discordant assessments on 
standard imaging. This finding shows that the complex motion patterns in combination 
with varying injection to scan delays not only affect the quantitative test-retest 
reproducibility but might also affect the clinical classification of lesions (Table 4, Figure 
5). In addition, the TBR measure may vary due to differences in the reconstruction 
protocols. In a recent study, it was found that the TBR is also dependent on the post-
filtering of the data and the number of iterations and subsets used [9]. The use of time-
of-flight and point-spread function corrections is expected to have a significant impact on 
the SUV assessment of the coronary lesions which often are of the same magnitude as 
the PET resolution [9]. In the current study, we used an already established reconstruction 
protocol which was used in previous studies from our center [7,15]. Further optimizations 
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of the reconstruction protocols with a focus on improved reproducibility could be still 
possible.  
 
Our findings show that a combination of comprehensive corrections for motion correction 
and injection to scan delays is critical for high reproducibility and consistent evaluation of 
lesions in coronary plaque imaging. To this end, the proposed correction techniques are 
applicable without the need for additional hardware or changes in the imaging protocols 
as motion and blood pool corrections, are performed using data obtained during standard 
acquisitions and can be performed retrospectively. The novel correction approaches 
presented in this study are directly applicable to ongoing clinical trials utilizing 18F-NaF 
coronary plaque imaging: DIAMOND (NCT02110303) and PREFFIR (NCT02278211) 
[22,23]. In principle, these motion correction methods may be also adapted to other 
coronary tracers and also to the 18F-NaF PET imaging of patients with aortic stenosis [24].  
Limitations 
In this study, the number of cardiac and respiratory gates was limited to 4, due to 
reductions in count-statistics for each gated reconstruction. This approach, with a 
relatively limited number of gates, leads to increased intra-frame motion. Further 
improvement may be possible with larger number of gates or by correcting for motion 
either before or during image reconstruction [25], although such corrections are not 
implemented in current reconstruction toolboxes. In our study, the motion correction of 
the attenuation correction maps was not applied for each of the gated reconstructions. 
This was not possible in the current setting as motion detection in projection space 
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(sinogram space) is not easily transformed into motion in image-space. This limitation, 
however, is thought to have less impact on the reproducibility than performing no 
corrections for patient motion and respiratory motion, which is the current standard. 
Future studies should address focus on optimization of motion correction of the 
attenuation correction for coronary PET imaging in addition to of the PET images.  
Another limitation is the number of patients included in this protocol. However, this test-
retest study involves repeating of the complex CTA and PET protocol. Obtaining more 
extensive scan-rescan data with larger cohorts is currently not possible due to cost, ethics 
and radiation dose concerns. Partially mitigating this limitation, the total number of 
evaluated lesions was substantially larger than number of patients. Nevertheless, the 
results presented here were statistically significant, unequivocally demonstrating that the 





 Test/retest assessment of coronary lesions is significantly affected by 
cardiorespiratory and gross patient motion as well as varying injection delays. Correcting 
for these factors in a retrospective fashion improved the reproducibility by up to 133%. 







Figure S1 is available online. This figure includes Bland-Altman plots of the Target to 
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Table 1: Patient demographics 
Demographics Value 
Age in years, mean ±SD  69.7±7.5 
Gender (Males) 16 (84) 
Body-mass Index (BMI)  27.6±4.0 
Cardiovascular risk factors  
Diabetes Mellitus (Type I/ Type II),  0 (0) / 2 (11) 
Current Smoker  2 (11) 
Hypertension  13 (68) 
Hyperlipidemia  19 (100)  
 
Continuous variables reported as mean ± SD; categorical variables reported as n (%)   
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Table 2: Average target to background ratios (TBR) and coefficient of 
reproducibility (Repro) for the end-diastolic (standard), static images (NO-MC), 
cardiac motion corrected (MC), cardiac and gross patient motion corrected (2xMC) 
and triple motion corrected (3xMC) images. 
IMAGE SET ALL LESIONS 18F-NAF-AVID 
 TBR Repro  P-value Improvement TBR Repro P-value Improvement 
STANDARD 1.18±0.48 0.437 - - 1.65±0.38 0.628 - - 
NO-MC 1.06±0.32 0.345 <0.001 26.5% 1.37±0.23 0.490 =0.004 28.2% 
MC  1.11±0.39 0.336 <0.001 30.1% 1.46±0.32 0.479 <0.001 31.1% 
2XMC 1.12±0.40 0.307 <0.001 42.3% 1.51±0.30 0.422 <0.001 49.0% 
3X MC 1.20±0.46 0.299 <0.001 46.1% 1.68±0.29 0.422 <0.001 49.0% 
Improvements of the TBR reproducibility were calculated against the standard. All 
incremental improvements (p-value) were tested using Pitman-Morgan tests, where 
p<0.05 were considered statistically significant).  Continuous variables reported as mean 




Table 3. Background standardized uptake value (SUVbackground) activities with and 
without the correction for injection-to-scan delay. 
Test-retest coefficients of reproducibility (Repro) of the SUVbackground were calculated for 
all datasets before and after corrections. All improvements were calculated against the 
standard, non-corrected background activities. Results of comparisons by Pitman-
Morgan tests with p-values <0.05 (bold) were considered statistically significant.  
Standard = end-diastolic PET, No-MC =Static images, MC= cardiac motion corrected 
(MC), 2xMC = combined cardiac and gross patient motion corrected, 3xMC 
cardiorespiratory and gross patient motion corrected. Continuous variables reported as 
mean ± SD.  
 
 
IMAGE SET ACQUIRED SUVBACKGROUND CORRECTED SUVBACKGROUND 
 SUV Repro P-value Improvement SUV Repro P-value Improvement 




















































Table 4: Target to background ratios (TBR) obtained before and after corrections 
for motion and injection-to-scan delay (BC). 
IMAGE SET ALL LESIONS NAF-AVID 
 TBR Repro P-value Improvement TBR Repro P-value Improvement 
STANDARD 1.18±0.48 0.437  - 1.65±0.38 0.628  - 
NO-MC+BC 1.04±0.31 0.341 <0.001 27.4% 1.32±0.23 0.489 
 
<0.001 28.5% 
STANDARD+BC 1.15±0.46 0.365 
 
<0.001 19.7% 1.59±0.34 0.501 
 
<0.001 25.3% 
MC + BC 1.11±0.36 0.288 
 
<0.001 51.7% 1.41±0.30 0.392 
 
<0.001 60.2% 
2XMC+ BC 1.09±0.36 0.278 
 
<0.001 57.0% 1.46±0.28 0.365 
 
<0.001 71.9% 
3XMC +BC 1.18±0.44 0.254 
 
<0.001 72.0% 1.63±0.26 0.354 
 
<0.001 77.6% 
Significant improvements in the TBR coefficient of reproducibility (repro) was observed 
for all corrected image sets. Improvements of reproducibility were calculated against the 
standard assessment. All incremental improvements were significant (P-value) by 
Pitman-Morgan test. 
Standard = end-diastolic PET, No-MC = Static, MC= cardiac motion corrected (MC), 
2xMC = combined cardiac and gross patient motion corrected, 3xMC cardiorespiratory 





Table 5:  Impact of motion correction and background blood pool correction (BC) 
on target-to-background ratios (TBR) of 18F-NaF-avid lesions with gross patient 
motion >10mm in at least one of the scans. 
IMAGE SET  TBR REPRO P-VALUE IMPROVEMENT 
STANDARD 
(NO CORRECTION) 
1.78±0.43 0.745 - - 
NO-MC + BC 1.37±0.25 0.588 <0.001 26.7% 
STANDARD + BC 1.72±0.39 0.576 <0.001 29.4% 
MC + BC 1.54±0.33 0.386 <0.001 93.1% 
2XMC + BC  1.57±0.32 0.348 <0.001 114.0% 
3XMC + BC 1.76±0.29 0.320 <0.001 132.8% 
Improvements of the TBR reproducibility (repro) were calculated against the standard 
assessment method. All incremental improvements were significant (p-value) by Pitman-
Morgan tests. 
BC = background blood pool correction, Standard = end-diastolic PET, No-MC = static, 
MC= cardiac motion corrected (MC), 2xMC = combined cardiac and gross patient motion 
corrected, 3xMC cardiorespiratory and gross patient motion corrected. Continuous 







Figure 1: Overall scheme for comprehensive motion detection and correction of 
coronary PET images. A fixed number of respiratory and electrocardiogram (ECG) gates 
were used. The number of gross patient motion (GPM) gates depended on the number 
of repositioning events the patient had during the acquisition. A 3D-mesh of gated 
reconstructions were obtained, which were registered to generate the 3xMC image set. 
Following the co-registration, the MC images (MC, 2xMC and 3xMC) were obtained by 




Figure 2: Reproducibility of coronary 18F-NaF uptake measurement with motion 
correction. Bland-Altman plots of the target-to-background (TBR) evaluations for all the 
lesions with and without motion correction. (A) Standard, (B) cardiac motion corrected 
(MC), (C) cardiac and gross patient motion corrected (2xMC) and, (D) cardiorespiratory 
and gross patient motion corrected (3xMC). Significant reductions in the 95% confidence 
intervals (orange lines) were observed for all motion corrected datasets in comparison to 





Figure 3: Reproducibility of coronary 18F-NaF uptake measurements and 
adjustments for blood pool clearance. Bland-Altman plots of the TBR assessment for 
all lesions observed in the study. Standard images without and with corrections for 
injection-to-scan delay (Standard+BC) are shown in panels A and B respectively. The 
fully corrected dataset (cardiorespiratory and gross patient motion corrected with BC 
(3xMC+BC)) is shown in panel C. Significant reductions in the 95% confidence interval 
(orange lines) were observed for each incremental correction step (Table 5). BC = 





Figure 4: Reproducibility of coronary 18F-NaF uptake measurement in patients with 
substantial gross patient motion. Bland-Altman plots of the target-to-background 
(TBR) assessment for 18F-NaF-avid lesions with gross patient motion >10 mm. Standard 
evaluations of the lesions without (Standard) and with correction for variances in the blood 
pool activity (Standard +BC) are shown in panels A and B. Panel C demonstrates the fully 
corrected dataset (cardiorespiratory and gross patient motion with BC (3xMC+BC)). 
Significant reductions in the 95% confidence interval (orange lines) were observed for 
each incremental correction step (Table 5). BC = background blood pool correction. 








Figure 5: Test-rest coronary PET reproducibility before and after corrections.  
Patient 1 Patient with significant respiratory and gross patient motion during the first scan 
(10.3 mm) and a 20-minute difference in the injection-to-scan delay leading to discrepant 
evaluations in the test-retest scans. Patient 2. Patient with several repositioning events 
(gross patient motion) during the acquisition, which in combination with the 
cardiorespiratory motion reduced the appearing tracer-uptake in the lesion. Both 
patients. In both cases 3xMC+BC reduced the intra-scan variability TBR evaluation of 
the lesion. Following 3xMC+BC the test-retest lesion evaluation was concordant (18F-
NaF-avid) in comparison to discordant test-retest evaluations obtained from the standard 
images in both cases. TBR = target to background value, BC = blood pool correction.  
Standard = end-diastolic imaging, 3xMC = cardiorespiratory and gross patient motion 
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